KMK Partners with Major Pharma Company in Recent RWE Study Analyzing Multiple Sclerosis Treatment Costs

KMK partners with a global healthcare company in a real-world evidence study to quantify the healthcare costs associated with Multiple Sclerosis relapse. MORRISTOWN, NEW JERSEY, UNITED STATES, January 14, 2021 /EINPresswire.com/ — People and their loved ones dealing with multiple sclerosis (MS) face many challenges. The disease can cause people’s immune systems to attack their […]